[A10BB04, glibornuride, The therapeutic efficacy of Glibornuride can be decreased when used in combination with Follitropin.]
[R03CC03, terbutaline, The risk or severity of adverse effects can be increased when Terbutaline is combined with Follitropin.]
[A10BB05, tolazamide, The therapeutic efficacy of Tolazamide can be decreased when used in combination with Follitropin.]
[V04CA01, tolbutamide, The therapeutic efficacy of Tolbutamide can be decreased when used in combination with Follitropin.]
[N06AX05, trazodone, The therapeutic efficacy of Follitropin can be decreased when used in combination with Trazodone.]
[N06AA06, trimipramine, The risk or severity of Cardiac Arrhythmia can be increased when Follitropin is combined with Trimipramine.]
[L01EX04, vandetanib, The therapeutic efficacy of Follitropin can be decreased when used in combination with Vandetanib.]
[L01EC01, vemurafenib, The therapeutic efficacy of Follitropin can be decreased when used in combination with Vemurafenib.]
[L01ED01, crizotinib, The therapeutic efficacy of Follitropin can be decreased when used in combination with Crizotinib.]
[L01EJ01, ruxolitinib, The therapeutic efficacy of Follitropin can be decreased when used in combination with Ruxolitinib.]
[L01EK01, axitinib, The therapeutic efficacy of Follitropin can be decreased when used in combination with Axitinib.]
[L01EA04, bosutinib, The therapeutic efficacy of Follitropin can be decreased when used in combination with Bosutinib.]
[L01EX05, regorafenib, The therapeutic efficacy of Follitropin can be decreased when used in combination with Regorafenib.]
[L01EX07, cabozantinib, The therapeutic efficacy of Follitropin can be decreased when used in combination with Cabozantinib.]
[L01EA05, ponatinib, The therapeutic efficacy of Follitropin can be decreased when used in combination with Ponatinib.]
[A10AE05, insulin detemir, The therapeutic efficacy of Insulin detemir can be decreased when used in combination with Follitropin.]
[L01EB03, afatinib, The therapeutic efficacy of Follitropin can be decreased when used in combination with Afatinib.]
[N06AX28, levomilnacipran, The therapeutic efficacy of Follitropin can be decreased when used in combination with Levomilnacipran.]
[L01EL01, ibrutinib, The therapeutic efficacy of Follitropin can be decreased when used in combination with Ibrutinib.]
[C07AB04, acebutolol, The risk or severity of adverse effects can be increased when Acebutolol is combined with Follitropin.]
[L01ED02, ceritinib, The therapeutic efficacy of Follitropin can be decreased when used in combination with Ceritinib.]
[L01EX09, nintedanib, The therapeutic efficacy of Follitropin can be decreased when used in combination with Nintedanib.]
[L01EX08, lenvatinib, The therapeutic efficacy of Follitropin can be decreased when used in combination with Lenvatinib.]
[A10AE06, insulin degludec, The therapeutic efficacy of Insulin degludec can be decreased when used in combination with Follitropin.]
[L01EB04, osimertinib, The therapeutic efficacy of Follitropin can be decreased when used in combination with Osimertinib.]
[L01ED03, alectinib, The therapeutic efficacy of Follitropin can be decreased when used in combination with Alectinib.]
[A10BB31, acetohexamide, The therapeutic efficacy of Acetohexamide can be decreased when used in combination with Follitropin.]
[N06AA19, amineptin, The risk or severity of Cardiac Arrhythmia can be increased when Follitropin is combined with Amineptine.]
[L01EX10, midostaurin, The therapeutic efficacy of Follitropin can be decreased when used in combination with Midostaurin.]
[L01ED04, brigatinib, The therapeutic efficacy of Follitropin can be decreased when used in combination with Brigatinib.]
[L01EH02, neratinib, The therapeutic efficacy of Follitropin can be decreased when used in combination with Neratinib.]
[L01EL02, acalabrutinib, The therapeutic efficacy of Follitropin can be decreased when used in combination with Acalabrutinib.]
[N06AA15, butriptyline, The risk or severity of Cardiac Arrhythmia can be increased when Follitropin is combined with Butriptyline.]
[B02BX09, fostamatinib, The therapeutic efficacy of Follitropin can be decreased when used in combination with Fostamatinib.]
[C07AB08, celiprolol, The risk or severity of adverse effects can be increased when Celiprolol is combined with Follitropin.]
[L01EB07, dacomitinib, The therapeutic efficacy of Follitropin can be decreased when used in combination with Dacomitinib.]
[A10BB06, carbutamide, The therapeutic efficacy of Carbutamide can be decreased when used in combination with Follitropin.]
[L01EX12, larotrectinib, The therapeutic efficacy of Follitropin can be decreased when used in combination with Larotrectinib.]
[L01EX13, gilteritinib, The therapeutic efficacy of Follitropin can be decreased when used in combination with Gilteritinib.]
[L01EN01, erdafitinib, The therapeutic efficacy of Follitropin can be decreased when used in combination with Erdafitinib.]
[L01EX15, pexidartinib, The therapeutic efficacy of Follitropin can be decreased when used in combination with Pexidartinib.]
[L01EJ02, fedratinib, The therapeutic efficacy of Follitropin can be decreased when used in combination with Fedratinib.]
[L01EX14, entrectinib, The therapeutic efficacy of Follitropin can be decreased when used in combination with Entrectinib.]
[A10AE03, insulin, regular, pork, The therapeutic efficacy of Insulin pork can be decreased when used in combination with Follitropin.]
[L01EX18, avapritinib, The therapeutic efficacy of Follitropin can be decreased when used in combination with Avapritinib.]
[L01EE04, selumetinib, The therapeutic efficacy of Follitropin can be decreased when used in combination with Selumetinib.]
[L01EH03, tucatinib, The therapeutic efficacy of Follitropin can be decreased when used in combination with Tucatinib.]
[L01EX17, capmatinib, The therapeutic efficacy of Follitropin can be decreased when used in combination with Capmatinib.]
[L01EX22, selpercatinib, The therapeutic efficacy of Follitropin can be decreased when used in combination with Selpercatinib.]
[A10BB02, chlorpropamide, The therapeutic efficacy of Chlorpropamide can be decreased when used in combination with Follitropin.]
[L01EX21, tepotinib, The therapeutic efficacy of Follitropin can be decreased when used in combination with Tepotinib.]
[N06BA08, fenozolone, The risk or severity of adverse effects can be increased when Fenozolone is combined with Follitropin.]
[A10AF01, insulin, regular, human, The therapeutic efficacy of Insulin human can be decreased when used in combination with Follitropin.]
[L01EK03, tivozanib, The therapeutic efficacy of Follitropin can be decreased when used in combination with Tivozanib.]
[L01EN03, infigratinib, The therapeutic efficacy of Follitropin can be decreased when used in combination with Infigratinib.]
[N06AB04, citalopram, The therapeutic efficacy of Follitropin can be decreased when used in combination with Citalopram.]
[A10BB12, glimepiride, The therapeutic efficacy of Glimepiride can be decreased when used in combination with Follitropin.]
[A10BB08, gliquidone, The therapeutic efficacy of Gliquidone can be decreased when used in combination with Follitropin.]
[R03CC13, clenbuterol, The risk or severity of adverse effects can be increased when Clenbuterol is combined with Follitropin.]
[L01EJ03, pacritinib, The therapeutic efficacy of Follitropin can be decreased when used in combination with Pacritinib.]
[N06AA04, clomipramine, The risk or severity of Cardiac Arrhythmia can be increased when Follitropin is combined with Clomipramine.]
[L04AA56, deucravacitinib, The therapeutic efficacy of Follitropin can be decreased when used in combination with Deucravacitinib.]
[A10AE04, insulin glargine, The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Follitropin.]
[L01EA01, imatinib, The therapeutic efficacy of Follitropin can be decreased when used in combination with Imatinib.]
[A08AA09, mefenorex, The risk or severity of adverse effects can be increased when Mefenorex is combined with Follitropin.]
[R03CB02, methoxyphenamine, The risk or severity of adverse effects can be increased when Methoxyphenamine is combined with Follitropin.]
[N06AX06, nefazodone, The therapeutic efficacy of Follitropin can be decreased when used in combination with Nefazodone.]
[N06AB10, escitalopram, The therapeutic efficacy of Follitropin can be decreased when used in combination with Escitalopram.]
[N06AA01, desipramine, The risk or severity of Cardiac Arrhythmia can be increased when Follitropin is combined with Desipramine.]
[L01EB01, gefitinib, The therapeutic efficacy of Follitropin can be decreased when used in combination with Gefitinib.]
[N06BA02, dextroamphetamine, The risk or severity of adverse effects can be increased when Amphetamine is combined with Follitropin.]
[N06AB05, paroxetine, The therapeutic efficacy of Follitropin can be decreased when used in combination with Paroxetine.]
[N05BA01, diazepam, The therapeutic efficacy of Follitropin can be decreased when used in combination with Diazepam.]
[N06AA08, dibenzepin, The risk or severity of Cardiac Arrhythmia can be increased when Follitropin is combined with Dibenzepin.]
[L01EB02, erlotinib, The therapeutic efficacy of Follitropin can be decreased when used in combination with Erlotinib.]
[A08AA03, diethylpropion, The risk or severity of adverse effects can be increased when Diethylpropion is combined with Follitropin.]
[R03CC08, procaterol, The risk or severity of adverse effects can be increased when Procaterol is combined with Follitropin.]
[N06AA23, quinupramine, The risk or severity of Cardiac Arrhythmia can be increased when Follitropin is combined with Quinupramine.]
[S01AX06, resorcinol, The therapeutic efficacy of Follitropin can be decreased when used in combination with Resorcinol.]
[L01EX01, sunitinib, The therapeutic efficacy of Follitropin can be decreased when used in combination with Sunitinib.]
[C01CA07, dobutamine, The risk or severity of adverse effects can be increased when Dobutamine is combined with Follitropin.]
[C01CA04, dopamine, The risk or severity of adverse effects can be increased when Dopamine is combined with Follitropin.]
[N06AA16, dothiepin, The risk or severity of Cardiac Arrhythmia can be increased when Follitropin is combined with Dosulepin.]
[N06AA12, doxepin, The risk or severity of Cardiac Arrhythmia can be increased when Follitropin is combined with Doxepin.]
[N06AB06, sertraline, The therapeutic efficacy of Follitropin can be decreased when used in combination with Sertraline.]
[A08AA10, sibutramine, The therapeutic efficacy of Follitropin can be decreased when used in combination with Sibutramine.]
[S01GA02, tetrahydrozoline, The risk or severity of adverse effects can be increased when Tetryzoline is combined with Follitropin.]
[N06AX14, tianeptine, The risk or severity of Cardiac Arrhythmia can be increased when Follitropin is combined with Tianeptine.]
[R01AA09, tramazoline, The risk or severity of adverse effects can be increased when Tramazoline is combined with Follitropin.]
[S01FB02, ephedrine, The risk or severity of adverse effects can be increased when Ephedrine is combined with Follitropin.]
[S01EA01, epinephrine, The risk or severity of adverse effects can be increased when Epinephrine is combined with Follitropin.]
[A10AB06, insulin glulisine, human, The therapeutic efficacy of Insulin glulisine can be decreased when used in combination with Follitropin.]
[C01CA15, gepefrine, The risk or severity of adverse effects can be increased when Gepefrine is combined with Follitropin.]
[J04AD03, ethionamide, The therapeutic efficacy of Follitropin can be decreased when used in combination with Ethionamide.]
[C01CA01, etilefrine, The risk or severity of adverse effects can be increased when Etilefrine is combined with Follitropin.]
[N06AB08, fluvoxamine, The therapeutic efficacy of Follitropin can be decreased when used in combination with Fluvoxamine.]
[R03CC04, fenoterol, The risk or severity of adverse effects can be increased when Fenoterol is combined with Follitropin.]
[N06AA14, melitracen, The risk or severity of Cardiac Arrhythmia can be increased when Follitropin is combined with Melitracen.]
[N06AB03, fluoxetine, The therapeutic efficacy of Follitropin can be decreased when used in combination with Fluoxetine.]
[L01EA02, dasatinib, The therapeutic efficacy of Follitropin can be decreased when used in combination with Dasatinib.]
[L01EH01, lapatinib, The therapeutic efficacy of Follitropin can be decreased when used in combination with Lapatinib.]
[A10BB01, glyburide, The therapeutic efficacy of Glyburide can be decreased when used in combination with Follitropin.]
[A10BB09, gliclazide, The therapeutic efficacy of Gliclazide can be decreased when used in combination with Follitropin.]
[A10BB07, glipizide, The therapeutic efficacy of Glipizide can be decreased when used in combination with Follitropin.]
[L01EX02, sorafenib, The therapeutic efficacy of Follitropin can be decreased when used in combination with Sorafenib.]
[A10AD05, insulin aspart, human, The therapeutic efficacy of Insulin aspart can be decreased when used in combination with Follitropin.]
[N06AA02, imipramine, The risk or severity of Cardiac Arrhythmia can be increased when Follitropin is combined with Imipramine.]
[N06AX17, milnacipran, The therapeutic efficacy of Follitropin can be decreased when used in combination with Milnacipran.]
[N06AA13, iprindole, The risk or severity of Cardiac Arrhythmia can be increased when Follitropin is combined with Iprindole.]
[R03CB01, isoproterenol, The risk or severity of adverse effects can be increased when Isoprenaline is combined with Follitropin.]
[C04AA01, isoxsuprine, The risk or severity of adverse effects can be increased when Isoxsuprine is combined with Follitropin.]
[C07AG01, labetalol, The risk or severity of adverse effects can be increased when Labetalol is combined with Follitropin.]
[N06AA07, lofepramine, The risk or severity of Cardiac Arrhythmia can be increased when Follitropin is combined with Lofepramine.]
[C10AA02, lovastatin, The therapeutic efficacy of Follitropin can be decreased when used in combination with Lovastatin.]
[L01EA03, nilotinib, The therapeutic efficacy of Follitropin can be decreased when used in combination with Nilotinib.]
[C01CA11, mephentermine, The risk or severity of adverse effects can be increased when Mephentermine is combined with Follitropin.]
[C01CA09, metaraminol, The risk or severity of adverse effects can be increased when Metaraminol is combined with Follitropin.]
[N06BA03, methamphetamine, The risk or severity of adverse effects can be increased when Metamfetamine is combined with Follitropin.]
[C01CA10, methoxamine, The risk or severity of adverse effects can be increased when Methoxamine is combined with Follitropin.]
[A03FA01, metoclopramide, The therapeutic efficacy of Follitropin can be decreased when used in combination with Metoclopramide.]
[C01CA17, midodrine, The risk or severity of adverse effects can be increased when Midodrine is combined with Follitropin.]
[N06BA12, lisdexamfetamine, The risk or severity of adverse effects can be increased when Lisdexamfetamine is combined with Follitropin.]
[L03AC01, aldesleukin, The therapeutic efficacy of Follitropin can be decreased when used in combination with Aldesleukin.]
[N06AA09, amitriptyline, The risk or severity of Cardiac Arrhythmia can be increased when Follitropin is combined with Amitriptyline.]
[L01EX03, pazopanib, The therapeutic efficacy of Follitropin can be decreased when used in combination with Pazopanib.]
[N06AA17, amoxapine, The risk or severity of Cardiac Arrhythmia can be increased when Follitropin is combined with Amoxapine.]
[S01GA01, naphazoline, The risk or severity of adverse effects can be increased when Naphazoline is combined with Follitropin.]
[N06BA01, amphetamine, The risk or severity of adverse effects can be increased when Amphetamine is combined with Follitropin.]
[N06AX21, duloxetine, The therapeutic efficacy of Follitropin can be decreased when used in combination with Duloxetine.]
[N06AX23, desvenlafaxine, The therapeutic efficacy of Follitropin can be decreased when used in combination with Desvenlafaxine.]
[C01CA03, norepinephrine, The risk or severity of adverse effects can be increased when Norepinephrine is combined with Follitropin.]
[N06AA10, nortriptyline, The risk or severity of Cardiac Arrhythmia can be increased when Follitropin is combined with Nortriptyline.]
[G02CA02, nylidrin, The risk or severity of adverse effects can be increased when Nylidrin is combined with Follitropin.]
[N06AA05, opipramol, The risk or severity of Cardiac Arrhythmia can be increased when Follitropin is combined with Opipramol.]
[R03CB03, metaproterenol, The risk or severity of adverse effects can be increased when Orciprenaline is combined with Follitropin.]
[S01GA04, oxymetazoline, The risk or severity of adverse effects can be increased when Oxymetazoline is combined with Follitropin.]
[J04AA01, aminosalicylic acid, The therapeutic efficacy of Follitropin can be decreased when used in combination with Aminosalicylic acid.]
[N05AB03, perphenazine, The therapeutic efficacy of Follitropin can be decreased when used in combination with Perphenazine.]
[A08AA01, phentermine, The risk or severity of adverse effects can be increased when Phentermine is combined with Follitropin.]
[S01GA05, phenylephrine, The risk or severity of adverse effects can be increased when Phenylephrine is combined with Follitropin.]
[R01BA01, phenylpropanolamine, The risk or severity of adverse effects can be increased when Phenylpropanolamine is combined with Follitropin.]
[A10AD04, insulin lispro, The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Follitropin.]
[N06AA11, protriptyline, The risk or severity of Cardiac Arrhythmia can be increased when Follitropin is combined with Protriptyline.]
[R01BA02, pseudoephedrine, The risk or severity of adverse effects can be increased when Pseudoephedrine is combined with Follitropin.]
[G02CA01, ritodrine, The risk or severity of adverse effects can be increased when Ritodrine is combined with Follitropin.]
